Table 1.

Cross-tabulation of referral cytology results and study cytology results

		Study Cytology
Referral Cytology	Statistics	NILM	ASC-US	LSIL	ASC-H	HSIL+	Missing	Total
ASC-US	N	54	30	22	19	12	3	140
	p16/ki-67+	14 (25.93%)	8 (26.67%)	16 (72.73%)	16 (84.21%)	12 (100%)	1 (33.33%)	67 (47.86%)
	CIN2+	4 (7.41%)	2 (6.67%)	8 (36.36%)	9 (47.37%)	10 (83.33%)	0 (0%)	33 (23.57%)
	CIN3+	1 (1.85%)	1 (3.33%)	2 (9.09%)	5 (26.32%)	3 (25%)	0 (0%)	12 (8.57%)
LSIL	N	49	53	88	21	45	8	264
	p16/ki-67+	10 (20.41%)	23 (43.40%)	58 (65.91%)	17 (80.95%)	42 (93.33%)	2 (25%)	152 (57.58%)
	CIN2+	4 (8.16%)	6 (11.32%)	31 (35.23%)	12 (57.14%)	36 (80%)	2 (25%)	91 (34.47%)
	CIN3+	0 (0%)	2 (3.77%)	5 (5.68%)	1 (4.76%)	11 (24.44%)	1 (12.50%)	20 (7.58%)
ASC-H	N	18	21	14	10	15	1	79
	p16/ki-67	1 (5.56%)	10 (47.62%)	12 (85.71%)	9 (90%)	15 (100%)	1 (100%)	48 (60.76%)
	CIN2+	4 (22.2%)	4 (19.05%)	10 (71.43%)	5 (50%)	15 (100%)	1 (100%)	39 (49.37%)
	CIN3+	1 (5.56%)	1 (4.76%)	1 (7.14%)	2 (20%)	5 (33.33%)	1 (100%)	10 (12.66%)
HSIL+	N	13	8	11	11	70	1	114
	p16/ki-67+	3 (23.08%)	3 (37.50%)	8 (72.73%)	9 (81.82%)	68 (87.14%)	1 (100%)	92 (80.70)
	CIN2+	3 (23.08%)	3 (37.50%)	7 (63.64%)	7 (63.64%)	63 (90.00%)	1 (100%)	84 (73.68%)
	CIN3+	0 (0%)	0 (0%)	3 (27.27%)	4 (36.36%)	34 (48.57%)	0 (0%)	41 (35.96%)
Missing	N	9	5	3	2	9	0	28
	p16/ki-67+	0 (0%)	3 (60%)	1 (33.33%)	1 (50%)	7 (77.78%)	0 (0%)	12 (42.86%)
	CIN2+	0 (0%)	1 (20%)	0 (0%)	1 (50%)	9 (100%)	0 (0%)	11 (39.29%)
	CIN3+	0 (0%)	0 (0%0	0 (0%)	0 (0%)	5 (55.56%)	0 (0%)	5 (17.86%)
Total	N	143	117	138	63	151	13	625
	p16/ki-67+	28 (19.58%)	47 (40.17%)	95 (68.84%)	52 (82.54%)	144 (95.36%)	5 (38.46%)	371 (59.36%)
	CIN2+	15 (10.49%)	16 (13.68%)	56 (40.58%)	34 (53.97%)	133 (88.08%)	4 (30.77%)	258 (41.28%)
	CIN3+	2 (1.40%)	4 (3.42%)	11 (7.97%)	12 (19.05%)	58 (38.41%)	1 (7.69%)	88 (14.08%)